LDA analysis for Study ST003429

(Analysis AN005631 )

Select 3 or more experimental factors for PCA analysis.
GroupExperimental factor
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:0.1 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:10 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:1 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:20 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:40 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:5 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Intracellular | Drug Treatment:Control
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:0.1 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:10 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:1 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:20 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:40 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:5 uM Fasnall
Sample source:BT-474 breast cancer cells | Sample Type:Medium | Drug Treatment:Control
Sample source:NA | Sample Type:Blank | Drug Treatment:NA
Sample source:NA | Sample Type:Medium | Drug Treatment:10 uM Fasnall
Sample source:NA | Sample Type:QC | Drug Treatment:NA

OR

Perform LDA on individual factors (all analyses in study)
  logo